Adverse events (AEs) commonly observed in both groups included neutropenia, nausea, and anemia. The AEs attributed to the addition of bevacizumab in the combination group were marginal, as grade 3 or ...

A research team investigating the use of the bacterium Listeria monocytogenes against colorectal cancer has discovered a way to build a modified version of Listeria as an oral vaccine to prime the ...

Initial Dose Adjustment of Zolbetuximab Plus Chemotherapy in CLDN18.2-Positive Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer (GENTLE-Z), a Randomized, Phase II Trial ...

Colorectal cancer remains the third most commonly diagnosed cancer in both men and women in the United States, with approximately 153,000 new cases expected this year alone. While overall rates have ...

The surgical outcomes of colon cancer vary with its anatomical location. Neoadjuvant chemotherapy can aid in improving the postsurgical outcomes of both right and left colon cancer, decreasing the ...

Leronlimab demonstrated partial or complete responses in advanced metastatic colorectal cancer, supporting its potential in solid tumor oncology. Increased PD-L1 expression in triple-negative breast ...

Researchers have developed and internally validated a simple score using clinical factors that can help estimate the likelihood of advanced colorectal neoplasia in adults younger than age 45 years.

More cases of colorectal cancer are detected at an early stage with screening. This is according to new research based on data from over 278,000 60-year-olds, who were randomly selected to undergo one ...

Forbes contributors publish independent expert analyses and insights. A physician who writes about challenges with navigating healthcare. Dr. Lara Lambert, an emergency medicine physician, was 36 when ...